Finished product reference
Asa / Codeine Phosphate
Tablet · Oral · 500 mg/10 mg
- List code
- 110
- Pharmacologic class
- Compound opioid analgesic (aspirin / codeine)
What it is and how it works
Aspirin inhibits cyclo-oxygenase, reducing prostaglandin-mediated pain and inflammation; codeine is a weak opioid agonist whose analgesic action depends mainly on CYP2D6-mediated conversion to morphine. The combination provides additive analgesia.
Indications
Short-term relief of acute moderate pain not relieved by simple analgesics alone.
Dosage and administration (summary)
Oral, usually 1–2 tablets every 4–6 hours as required, within maximum daily limits for aspirin and codeine (240 mg); treatment should be limited to about 3 days.
Contraindications
Children and adolescents under 16 years (aspirin) and under 12 years (codeine); CYP2D6 ultra-rapid metabolisers; breastfeeding; active peptic ulcer or bleeding disorders; aspirin or NSAID hypersensitivity; acute respiratory depression; third trimester of pregnancy.
Warnings and precautions
Risk of gastrointestinal bleeding, respiratory depression, dependence and medication-overuse headache. Caution with anticoagulants, CNS depressants and alcohol, and in asthma, renal or hepatic impairment. Causes constipation and drowsiness.
Pregnancy
Avoid in pregnancy; contraindicated in the third trimester.
Storage and supply
Store below 25 °C, protected from moisture.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.